CHARACTERISE - A Cross-sectional, Observational Study to Characterise the Transition to Dolutegravir-based Regimens in South Africa in Terms of the Emergence of Obesity, Viral Re-suppression and Integration Into Routine Programme Care
Clinical trial NCT05502692 · COMPLETED
Trial details
- NCT number
- NCT05502692
- Sponsor
- University of Witwatersrand, South Africa
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-12
- Primary completion
- 2022-12-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.